Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric study.

Front Endocrinol (Lausanne) · 2024 · PMC10867143 · PMID 38362280

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The GH and IGF1 levels had a decreasing trend, though not statistically significant, between month 6 [GH 0.98 (0.85-1.7) ng/mL, IGF-1 1.00 (0.65-1.28)xULN], month 12 [GH 0.85 (0.42-1.82) ng/mL, IGF-1 0.71 (0.57-1.17)xULN] and last follow-up [GH 0.74 (0.29-1.21) ng/mL, IGF-1 0.70 (0.57-0.98)xULN] (p >0.30 for all comparisons.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.